Investment
Features
FeesSafety
Academy
More
Pluang+

Citigroup upgraded to hold after strong Q2 results, dividend hike, and $30B buyback amid cautious macro outlook.

Analyst Insights
01 Oct 2026
Seeking Alpha
View Source
Bullish
Citigroup upgraded to hold after strong Q2 results, dividend hike, and $30B buyback amid cautious macro outlook.

Citigroup's strong Q2 performance, including a 12% dividend increase and a $30 billion share buyback, has led to an upgrade to hold by analyst Ian Bezek. Despite solid fundamentals, sector-wide risks from rising interest rates and a flat yield curve could pressure valuations. The upgrade reflects confidence in Citi's capital returns but remains cautious due to uncertain macroeconomic conditions. Investors are advised to watch for a more favorable economic environment before becoming more bullish on the stock.

As of Oct 02, 2026 03:21 WIB, Citigroup shares trade at USD 127.17 on Pluang, down 1.82% in the last day. The stock shows a dividend yield of 2.07% and a market cap of $217.19 billion. Despite the recent downgrade in daily price, investor interest remains balanced with 58% buy orders on the platform, reflecting ongoing engagement amid macroeconomic uncertainties.

More News (C)

Money-center bank stocks fall, Citigroup down 4%, Bank of America 3%, JPMorgan 0.9% amid legal and positioning pressures

Money-center bank stocks fall, Citigroup down 4%, Bank of America 3%, JPMorgan 0.9% amid legal and positioning pressures

Shares of major U.S. money-center banks declined, with Citigroup falling 4%, Bank of America down 3%, and JPMorgan Chase slipping 0.9%. Bank of America's drop follows a $39 million settlement over Merrill Lynch cash sweep accounts, but this legal iss...

Market News
Bearish
10 hours ago
Moderna stock rises 3% despite Citigroup downgrade over valuation concerns

Moderna stock rises 3% despite Citigroup downgrade over valuation concerns

Moderna shares climbed 3% even after Citigroup downgraded the stock to Sell, citing high valuation following a 222% rise since positive melanoma vaccine trial results. The market seems optimistic about Moderna's personalized cancer vaccine pipeline, ...

Market News
Bullish
11 hours ago
Rocket Lab shares jump 5% on record Electron launch deal, backlog tops 100 missions.

Rocket Lab shares jump 5% on record Electron launch deal, backlog tops 100 missions.

Rocket Lab secured its largest-ever Electron launch contract with Tokyo-based Synspective for 20 missions over several years, pushing its launch backlog beyond 100 missions. This multi-year deal, combined with a new Buy rating and $105 price target f...

Market News
Bullish
12 hours ago
Citigroup keeps 'Buy' on Zymeworks after acquisition boosts 2026 revenue outlook to $278-$292M

Citigroup keeps 'Buy' on Zymeworks after acquisition boosts 2026 revenue outlook to $278-$292M

Citigroup maintains a 'Buy' rating for Zymeworks Inc. following its strategic acquisition of Theravance Biopharma, which aims to diversify cash flows and combine R&D with revenue-generating assets. The acquisition includes the product YUPELRI, expect...

Analyst Insights
Bullish
2 days ago
SoFi shares drop 43% in a year despite a Citi analyst's bullish call to nearly double in 12 months.

SoFi shares drop 43% in a year despite a Citi analyst's bullish call to nearly double in 12 months.

SoFi Technologies' stock has fallen over 43% in the past year, trading near its 52-week low at $15.93. Despite this, a Citigroup analyst maintains a strong Buy rating with a $30 target, suggesting an 88% upside based on SoFi's growing deposits, cross...

Analyst Insights
Bullish
2 days ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App